Archetype was adopted for intractable disease surveillance
Japan has intractable disease (so called 'nanbyo' in Japanese) surveillance and subsidy program. Intractable disease is defined as rare and chronically progressive diseases, which cause patients disability and social and financial burden. eg. Systemic lupus erythematosus, dermatomyositis, myasthenia gravis, ulcerative colitis and so on. To get more outcome from this program, data repository will be reconstructed with archetype technology. We are now modeling the clinical research forms and making archetypes. This is the first practical step of the openEHR in Japan. Shinji KOBAYASHI -- KOBAYASHI, Shinji <skoba@moss.gr.jp> _______________________________________________ openEHR-clinical mailing list openEHR-clinical@openehr.org http://lists.chime.ucl.ac.uk/mailman/listinfo/openehr-clinical